IRS1 and polycystic ovary syndrome: These findings suggest the role of both a serine kinase external to the insulin receptor and the constitutive activation of the MAPK/ERK pathway, which impairs metabolic signaling in PCOS via serine phosphorylation of IRS-1/insulin receptor.